retatrutide phase 3 trials just delivered the first top-line results for a triple agonist in obesity — and the findings from TRIUMPH-4 are striking👇 Lilly's triple agonist, retatrutide, delivered

In addition, resident microglia of the CNS, infiltrating monocytes, and neutrophils secrete IL-1 and IL-23 to activate further and expand these cells [128]

Retatrutide reduces total body fat with particular effectiveness for liver fat

This is because obesity is a major risk factor for numerous health conditions, including heart disease, stroke, high blood pressure and at least 13 different types of cancer, according to the Centers for Disease Control and Prevention

Taking each day closer to a healthier, more vibrant life How to Take GLP-1 Supplement: Take 2 capsules, 1 time per day 15 to 30 minutes before meals, 60 days supply per bottle

The company said its own research found that patients could sustain weight loss after stopping obesity drugs

Unlike name-brand GLP-1s, compounded versions arent reviewed by the FDA for safety, quality or effectiveness